Targeting the Lung Using siRNA and Antisense Based Oligonucleotides

E-ISSN： 1873-4286|14|34|3620-3627

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.14, Iss.34, 2008-12, pp. : 3620-3627

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Oral delivery of siRNA and antisense oligonucleotides

By Akhtar Saghir

Journal of Drug Targeting, Vol. 17, Iss. 7, 2009-08 ,pp. : 491-495

Informa Healthcare

Access to resources Recommend Favorite

Cationic derivatives of biocompatible hyaluronic acids for delivery of siRNA and antisense oligonucleotides

By Han Su-Eun Kang Hyungu Shim Ga Yong Kim Sun Jae Choi Han-Gon KIM JISEOK HAHN SEI KWANG Oh Yu-Kyoung

Journal of Drug Targeting, Vol. 17, Iss. 2, 2009-02 ,pp. : 123-132

Informa Healthcare

Access to resources Recommend Favorite

The role of carrier size in the pharmacodynamics of antisense and siRNA oligonucleotides

By Huang Leaf Sullenger Bruce Juliano Rudy

Journal of Drug Targeting, Vol. 18, Iss. 8, 2010-09 ,pp. : 567-574

Informa Healthcare

Access to resources Recommend Favorite

Receptors, endocytosis, and trafficking: the biological basis of targeted delivery of antisense and siRNA oligonucleotides

By Juliano R. L. Carver K. Cao C. Ming X.

Journal of Drug Targeting, Vol. 21, Iss. 1, 2013-01 ,pp. : 27-43

Informa Healthcare

Access to resources Recommend Favorite

Killing the Messenger: Antisense DNA and siRNA

Current Drug Targets, Vol. 5, Iss. 8, 2004-11 ,pp. : 683-689

Bentham Science Publishers

Access to resources Recommend Favorite